Study identity card

BUCOSS RSV 60+

Germany
Share
  • Disease: COVID-19, Influenza, Respiratory syncytial virus infection
  • Study type: Observational Cohort Study, Natural History
  • Study type descriptors: Prospective, Multicentre
  • Objective: To conduct prospective surveillance of acute respiratory infections (ARI) in out-patients attributable to RSV, including the impact of comorbidities, resulting complications, economic and quality of life (QoL) impact on out-patients
  • Number of participants enrolled: 3261
  • Study enrolling from to
  • Study includes follow-up for 28 days
  • Standardisation: ICD-10

Study Data

  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Primary care
  • SARS-CoV-2
  • Respiratory syncytial virus
  • Influenza virus
  • Respiratory syncytial virus infection
  • Influenza
  • COVID-19

Other information

Funders/Sponsors:

  • GlaxoSmithKline (Belgium)

If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it

The data is updated up to